Alexander C J, Citron D M, Brazier J S, Goldstein E J
R. M. Alden Research Laboratory, Santa Monica Hospital Medical Center, California 90404, USA.
J Clin Microbiol. 1995 Dec;33(12):3209-15. doi: 10.1128/jcm.33.12.3209-3215.1995.
Clostridium ramosum, C. innocuum, and C. clostridioforme are frequently isolated from clinical specimens including blood. Because of Gram stain variability, a lack of spores, and atypical colonial morphology, identification of these species is often difficult. Three anaerobe identification kits were evaluated for their abilities to identify these species. For comparison, 11 strains of C. perfringens were evaluated in parallel. By using profile numbers and codebooks, the correct genus and species were identified, as follows: with the RapID ANA II kit, 100% (20 of 20) of C. ramosum isolates, 24% (5 of 21) of C. innocuum isolates, and 50% (10 of 20) of C. clostridioforme isolates; with the AnIDent kit, 60% (12 of 20) of C. ramosum isolates, 28% (6 of 21) of C. innocuum isolates, and 90% (18 of 20) of C. clostridioforme isolates; with the ATB32A kit, 70% (14 of 20) of C. ramosum isolates, 0% (0 of 21) of C. innocuum isolates, and 40% (8 of 20) of C. clostridioforme isolates. Profile numbers that overlapped several species were obtained as follows: with the RapID ANA II kit, 0% of C. ramosum isolates, 76% of C. innocuum isolates, and 40% of C. clostridioforme isolates; with the AnIDent kit 40% of C. ramosum isolates, 62% of C. innocuum isolates, and 5% of C. clostridioforme isolates; with the ATB32A kit, 15% of C. ramosum isolates, 52% of C. innocuum isolates, and 25% of C. clostridioforme isolates. One strain of C. innocuum was misidentified by the AnIDent kit, and the remainder yielded profile numbers that were not listed in the codebooks. The MICs of 11 antimicrobial agents including penicillin G, metronidazole, clindamycin, cefoxitin, cefotetan, imipenem, meropenem, amoxicillin-clavulanate, ampicillin-sulbactam, piperacillin-tazobactam, and vancomycin were determined by the agar dilution method. All C. perfringens strains were susceptible to all antimicrobial agents tested. Various levels of resistance to cefoxitin, cefotetan, and penicillin G were noted with C. ramosum, C. clostridioforme, and C. innocuum. In addition, resistance to clindamycin was noted with C. ramosum (5%) and C. innocuum (10%). Most strains of C. innocuum were only moderately susceptible to vancomycin (MIC at which 90% of strains are inhibited, 4 micrograms/ml).
多枝梭菌、无害梭菌和梭形梭菌经常从包括血液在内的临床标本中分离出来。由于革兰氏染色的变异性、缺乏芽孢以及非典型的菌落形态,这些菌种的鉴定往往很困难。对三种厌氧菌鉴定试剂盒鉴定这些菌种的能力进行了评估。为作比较,同时对11株产气荚膜梭菌进行了评估。通过使用特征编码和编码手册,正确鉴定出了属和种,结果如下:使用RapID ANA II试剂盒,多枝梭菌分离株的鉴定正确率为100%(20株中的20株),无害梭菌分离株为24%(21株中的5株),梭形梭菌分离株为50%(20株中的10株);使用AnIDent试剂盒,多枝梭菌分离株为60%(20株中的12株),无害梭菌分离株为28%(21株中的6株),梭形梭菌分离株为90%(20株中的18株);使用ATB32A试剂盒,多枝梭菌分离株为70%(20株中的14株),无害梭菌分离株为0%(21株中的0株),梭形梭菌分离株为40%(20株中的8株)。获得的与几种菌种重叠的特征编码情况如下:使用RapID ANA II试剂盒,多枝梭菌分离株为0%,无害梭菌分离株为7***%,梭形梭菌分离株为40%;使用AnIDent试剂盒,多枝梭菌分离株为40%,无害梭菌分离株为62%,梭形梭菌分离株为5%;使用ATB32A试剂盒,多枝梭菌分离株为15%,无害梭菌分离株为52%,梭形梭菌分离株为25%。AnIDent试剂盒将1株无害梭菌误鉴定,其余菌株产生的特征编码未列在编码手册中。采用琼脂稀释法测定了包括青霉素G、甲硝唑、克林霉素、头孢西丁、头孢替坦、亚胺培南、美罗培南、阿莫西林-克拉维酸、氨苄西林-舒巴坦、哌拉西林-他唑巴坦和万古霉素在内的11种抗菌药物的最低抑菌浓度(MIC)。所有产气荚膜梭菌菌株对所有测试抗菌药物均敏感。多枝梭菌、梭形梭菌和无害梭菌对头孢西丁、头孢替坦和青霉素G呈现出不同程度的耐药性。此外,多枝梭菌(5%)和无害梭菌(10%)对克林霉素耐药。大多数无害梭菌菌株对万古霉素仅为中度敏感(90%菌株被抑制时的MIC为4微克/毫升)。